Skip to main content
Mylan’s remdesivir gets DCGI’s emergency authorisation for covid-19 treatment - Livemint 07-Jul-2020
Mylan’s remdesivir gets DCGI’s emergency authorisation for covid-19 treatment - Livemint
'The drug will be available to patients in July at a price of ₹4,800, which is more than 80% less than the price at which the branded version of this product will be available to governments in the developed world,' says Mylan
More...